SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)

The National Institutes of Health (NIH) is inviting applications from eligible small businesses for the Small Business Innovation Research (SBIR) program to develop solutions that enable population genomic screening for common, actionable genomic conditions in primary care settings. The objective is to create products or services that facilitate the implementation and sustainability of genomic screening efforts, addressing barriers such as education for primary care providers, efficient workflows, and effective referral systems. This initiative is crucial as it aims to improve early detection and management of hereditary conditions, ultimately enhancing patient outcomes and reducing healthcare costs. Interested applicants should note that the application due date is December 2, 2024, and are encouraged to contact Renee Rider at Renee.Rider@nih.gov for pre-application inquiries.